WIM INVESTMENT MANAGEMENT Ltd Makes New Investment in Grail, Inc. (NASDAQ:GRAL)

WIM INVESTMENT MANAGEMENT Ltd bought a new stake in Grail, Inc. (NASDAQ:GRAL - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 21,000 shares of the company's stock, valued at approximately $375,000. Grail comprises approximately 0.1% of WIM INVESTMENT MANAGEMENT Ltd's holdings, making the stock its 15th biggest holding. WIM INVESTMENT MANAGEMENT Ltd owned approximately 0.06% of Grail at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the business. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in Grail during the fourth quarter worth approximately $244,000. Moloney Securities Asset Management LLC purchased a new position in shares of Grail in the 4th quarter valued at $559,000. Rhumbline Advisers purchased a new position in shares of Grail in the 4th quarter valued at $456,000. Wesbanco Bank Inc. acquired a new stake in Grail during the 4th quarter worth $523,000. Finally, Slow Capital Inc. purchased a new stake in Grail in the fourth quarter valued at $2,379,000.

Wall Street Analyst Weigh In

Separately, Morgan Stanley lifted their target price on Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a research report on Tuesday, March 18th.

Grail Price Performance

NASDAQ GRAL traded up $2.48 on Friday, reaching $30.29. The stock had a trading volume of 1,739,247 shares, compared to its average volume of 1,224,238. The business's 50-day moving average price is $32.87 and its 200 day moving average price is $21.85. Grail, Inc. has a 12-month low of $12.33 and a 12-month high of $63.99.

Remove Ads

Grail (NASDAQ:GRAL - Get Free Report) last announced its earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, beating analysts' consensus estimates of ($4.41) by $2.55. The business had revenue of $38.25 million during the quarter, compared to analysts' expectations of $35.33 million. On average, research analysts forecast that Grail, Inc. will post -15.15 earnings per share for the current year.

Insider Buying and Selling at Grail

In other news, CFO Aaron Freidin sold 1,816 shares of Grail stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.20, for a total transaction of $56,659.20. Following the completion of the sale, the chief financial officer now directly owns 335,170 shares in the company, valued at approximately $10,457,304. This trade represents a 0.54 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Robert P. Ragusa sold 7,625 shares of the firm's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.21, for a total value of $237,976.25. Following the completion of the transaction, the chief executive officer now owns 828,662 shares of the company's stock, valued at approximately $25,862,541.02. This represents a 0.91 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 11,550 shares of company stock valued at $360,436.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.